AGN-231868 / Eurobio Scientific, AbbVie  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AGN-231868 / AbbVie
NCT04030962: A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

Completed
1/2
292
US
AGN-242428, AGN-231868, AGN-242428 Vehicle, AGN-231868 Vehicle, Lifitegrast 5% Ophthalmic Solution, Xiidra
AbbVie
Dry Eye Disease, Dry Eye Syndrome
03/22
03/22

Download Options